ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice

Neurobiology of Aging

Volumn 34, Issue 3, 2013, Pages 863-872

  Segev, Yifat ^a   Michaelson, Daniel M ^b   Rosenblum, Kobi ^a  

^a UNIVERSITY OF HAIFA   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

EIF2 ; Translation regulation

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; INITIATION FACTOR 2ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PRESENILIN 1; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEAR; GENETIC PREDISPOSITION; GENETIC RISK; LEARNING DISORDER; MALE; METABOLIC STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; WESTERN BLOTTING;

AGING; ANIMALS; APOLIPOPROTEIN E4; BRAIN; CEREBRAL CORTEX; COGNITION DISORDERS; EUKARYOTIC INITIATION FACTOR-2; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, TRANSGENIC; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84870522405     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.06.020     Document Type: Article

References (74)

1. Albert M., Blacker D., Moss M.B., Tanzi R., McArdle J.J. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology 2007, 21:158-169.
2. Anagnostaras S.G., Maren S., Sage J.R., Goodrich S., Fanselow M.S. Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology 1999, 21:731-744.
3. Bando Y., Onuki R., Katayama T., Manabe T., Kudo T., Taira K., Tohyama M. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem. Int. 2005, 46:11-18.
4. Bartrés-Faz D., Junqué C., Moral P., López-Alomar A., Sánchez-Aldeguer J., Clemente I.C. Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment. J. Neuropsychiatry Clin. Neurosci. 2002, 14:80-83.
5. Baxter L.C., Caselli R.J., Johnson S.C., Reiman E., Osborne D. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol. Aging 2003, 24:947-952.
6. Belelovsky K., Elkobi A., Kaphzan H., Nairn A.C., Rosenblum K. A molecular switch for translational control in taste memory consolidation. Eur. J. Neurosci. 2005, 22:2560-2568.
7. Belelovsky K., Kaphzan H., Elkobi A., Rosenblum K. Biphasic activation of the mTOR pathway in the gustatory cortex is correlated with and necessary for taste learning. J. Neurosci. 2009, 29:7424-7431.
8. Belinson H., Lev D., Masliah E., Michaelson D.M. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J. Neurosci. 2008, 28:4690-4701.
9. Belinson H., Michaelson D.M. Pathological synergism between amyloid-beta and apolipoprotein E4-the most prevalent yet understudied genetic risk factor for Alzheimer's disease. J. Alzheimers Dis. 2009, 17:469-481.
10. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9:768-778.
11. Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.
12. Bour A., Grootendorst J., Vogel E., Kelche C., Dodart J.C., Bales K., Moreau P.H., Sullivan P.M., Mathis C. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav. Brain Res. 2008, 193:174-182.
13. Cammalleri M., Lütjens R., Berton F., King A.R., Simpson C., Francesconi W., Sanna P.P. Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14368-14373.
14. Casadio A., Martin K.C., Giustetto M., Zhu H., Chen M., Bartsch D., Bailey C.H., Kandel E.R. A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 1999, 99:221-237.
15. Chang R.C., Wong A.K., Ng H.K., Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 2002, 13:2429-2432.
16. Cohen-Matsliah S.I., Seroussi Y., Rosenblum K., Barkai E. Persistent ERK activation maintains learning-induced long-lasting modulation of synaptic connectivity. Learn. Mem. 2008, 15:756-761.
17. Colton C.A., Brown C.M., Cook D., Needham L.K., Xu Q., Czapiga M., Saunders A.M., Schmechel D.E., Rasheed K., Vitek M.P. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol. Aging 2002, 23:777-785.
18. Costa-Mattioli M., Gobert D., Harding H., Herdy B., Azzi M., Bruno M., Bidinosti M., Ben Mamou C., Marcinkiewicz E., Yoshida M., Imataka H., Cuello A.C., Seidah N., Sossin W., Lacaille J.C., Ron D., Nader K., Sonenberg N. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 2005, 436:1166-1173.
19. Costa-Mattioli M., Gobert D., Stern E., Gamache K., Colina R., Cuello C., Sossin W., Kaufman R., Pelletier J., Rosenblum K., Krnjević K., Lacaille J.C., Nader K., Sonenberg N. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 2007, 129:195-206.
20. Costa-Mattioli M., Sonenberg N. Translational control of gene expression: a molecular switch for memory storage. Prog. Brain Res. 2008, 169:81-95.
21. Daumas S., Halley H., Francés B., Lassalle J.M. Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn. Mem 2005, 12:375-382.
22. Deane R., Sagare A., Hamm K., Parisi M., Lane S., Finn M.B., Holtzman D.M., Zlokovic B.V. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 2008, 118:4002-4013.
23. Dever T.E. Gene-specific regulation by general translation factors. Cell 2002, 108:545-556.
24. Dhikav V., Anand K. Potential predictors of hippocampal atrophy in Alzheimer's disease. Drugs Aging 2011, 28:1-11.
25. Dik M.G., Jonker C., Comijs H.C., Bouter L.M., Twisk J.W., van Kamp G.J., Deeg D.J. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology 2001, 57:2217-2222.
26. Fernandez J., Yaman I., Sarnow P., Snider M.D., Hatzoglou M. Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2alpha. J. Biol. Chem. 2002, 277:19198-19205.
27. Flory J.D., Manuck S.B., Ferrell R.E., Ryan C.M., Muldoon M.F. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am. J. Med. Genet. 2000, 96:707-711.
28. Galimberti D., Scarpini E. Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches. Curr. Aging Sci. 2010, 3:46-56.
29. Gelinas J.N., Banko J.L., Hou L., Sonenberg N., Weeber E.J., Klann E., Nguyen P.V. ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation. J. Biol. Chem. 2007, 282:27527-27535.
30. Giovannini M.G. The role of the extracellular signal-regulated kinase pathway in memory encoding. Rev. Neurosci. 2006, 17:619-634.
31. Gong J.S., Morita S.Y., Kobayashi M., Handa T., Fujita S.C., Yanagisawa K., Michikawa M. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons. Mol. Neurodegener. 2007, 2:9.
32. Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P.M., Dodart J.C., Bales K., Mathis C. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav. Brain Res. 2005, 159:1-14.
33. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 2000, 6:1099-1108.
34. Hartman R.E., Wozniak D.F., Nardi A., Olney J.W., Sartorius L., Holtzman D.M. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp. Neurol. 2001, 170:326-344.
35. Holcik M., Sonenberg N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 2005, 6:318-327.
36. Horwood J.M., Dufour F., Laroche S., Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur. J. Neurosci. 2006, 23:3375-3384.
37. Jofre-Monseny L., Minihane A.M., Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 2008, 52:131-145.
38. Kim H.S., Choi Y., Shin K.Y., Joo Y., Lee Y.K., Jung S.Y., Suh Y.H., Kim J.H. Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo. J. Neurosci. Res. 2007, 85:1528-1537.
39. Kim J., Basak J.M., Holtzman D.M. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009, 63:287-303.
40. Kimball S.R., Vary T.C., Jefferson L.S. Age-dependent decrease in the amount of eukaryotic initiation factor 2 in various rat tissues. Biochem. J. 1992, 286:263-268.
41. Ladiges W., Morton J., Blakely C., Gale M. Tissue specific expression of PKR protein kinase in aging B6D2F1 mice. Mech. Ageing Dev. 2000, 114:123-132.
42. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
43. Lauderback C.M., Hackett J.M., Keller J.N., Varadarajan S., Szweda L., Kindy M., Markesbery W.R., Butterfield D.A. Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease. Biochemistry 2001, 40:2548-2554.
44. LeDoux J.E., Cicchetti P., Xagoraris A., Romanski L.M. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 1990, 10:1062-1069.
45. Lind J., Larsson A., Persson J., Ingvar M., Nilsson L.G., Bäckman L., Adolfsson R., Cruts M., Sleegers K., Van Broeckhoven C., Nyberg L. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci. Lett. 2006, 396:23-27.1.
46. Morel M., Couturier J., Lafay-Chebassier C., Paccalin M., Page G. PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. J. Cell. Mol. Med. 2009, 13:1476-1488.
47. Morel M., Couturier J., Pontcharraud R., Gil R., Fauconneau B., Paccalin M., Page G. Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: role of p53, Redd1 and TSC2. Neurobiol. Dis. 2009, 36:151-161.
48. Naidoo N., Ferber M., Master M., Zhu Y., Pack A.I. Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J. Neurosci. 2008, 28:6539-6548.
49. O'Connor T., Sadleir K.R., Maus E., Velliquette R.A., Zhao J., Cole S.L., Eimer W.A., Hitt B., Bembinster L.A., Lammich S., Lichtenthaler S.F., Hébert S.S., De Strooper B., Haass C., Bennett D.A., Vassar R. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 2008, 60:988-1009.
50. Ohta K., Mizuno A., Ueda M., Li S., Suzuki Y., Hida Y., Hayakawa-Yano Y., Itoh M., Ohta E., Kobori M., Nakagawa T. Autophagy impairment stimulates PS1 expression and gamma-secretase activity. Autophagy 2010, 6:345-352.
51. Page G., Rioux Bilan A., Ingrand S., Lafay-Chebassier C., Pain S., Perault Pochat M.C., Bouras C., Bayer T., Hugon J. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 2006, 139:1343-1354.
52. Peel A.L., Bredesen D.E. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 2003, 14:52-62.
53. Pei J.J., Hugon J. mTOR-dependent signalling in Alzheimer's disease. J. Cell. Mol. Med. 2008, 12:2525-2532.
54. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106:274-285.
55. Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 1987, 917:148-161.
56. Rall S.C., Weisgraber K.H., Mahley R.W. Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 1982, 257:4171-4178.
57. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:284-289.
58. Richter J.D., Klann E. Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev. 2009, 23:1-11.
59. Ringman J.M., Cummings J.L. Current and emerging pharmacological treatment options for dementia. Behav. Neurol. 2006, 17:5-16.
60. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8:519-529.
61. Rosenblum K., Futter M., Voss K., Erent M., Skehel P.A., French P., Obosi L., Jones M.W., Bliss T.V. The role of extracellular regulated kinases I/II in late-phase long-term potentiation. J. Neurosci. 2002, 22:5432-5441.
62. Scheuner D., Vander Mierde D., Song B., Flamez D., Creemers J.W., Tsukamoto K., Ribick M., Schuit F.C., Kaufman R.J. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat. Med. 2005, 11:757-764.
63. Snowdon D.A., Kemper S.J., Mortimer J.A., Greiner L.H., Wekstein D.R., Markesbery W.R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996, 275:528-532.
64. Sonenberg N., Hershey J.W.B., Mathews M.B. Translational Control of Gene Expression 2000, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
65. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 1996, 19:53-77.
66. Sullivan P.M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R.L., Quarfordt S.H., Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 1997, 272:17972-17980.
67. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 2004, 14:311-317.
68. Tang S.J., Reis G., Kang H., Gingras A.C., Sonenberg N., Schuman E.M. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:467-472.
69. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
70. Tsokas P., Ma T., Iyengar R., Landau E.M., Blitzer R.D. Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway. J. Neurosci. 2007, 27:5885-5894.
71. Uchihara T., Duyckaerts C., He Y., Kobayashi K., Seilhean D., Amouyel P., Hauw J.J. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci. Lett. 1995, 195:5-8.
72. Wang X., Proud C.G. Methods for studying signal-dependent regulation of translation factor activity. Methods Enzymol. 2007, 431:113-142.
73. Xu P.T., Schmechel D., Qiu H.L., Herbstreith M., Rothrock-Christian T., Eyster M., Roses A.D., Gilbert J.R. Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice. Neurobiol. Dis. 1999, 6:63-75.
74. Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R.W., Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 2006, 26:4985-4994.